Rachlin, Lillian
December 1972
Angiology;Dec1972, Vol. 23 Issue 11, p651
Academic Journal
Evaluates the level of zinc in the aorta of patients with peripheral vascular disease. Benefits of patients from zinc sulfate therapy; Zinc composition in the arterial wall; Detection of subendothelial accumulation of cholesterol esters, triglycerides and phospholipids in atherosclerotic plaques.


Related Articles

  • Peripheral Arterial Disease. Anand, Sonia S.; Creager, Mark A. // American Family Physician;6/1/2002, Vol. 65 Issue 11, p2321 

    Presents information on the peripheral arterial disease. Symptoms of atheroma; Factors associated with the development of peripheral arterial disease; Comparison between the effectiveness of antiplatelet agents and control treatments in reducing the rate of cardiovascular events and local...

  • When walking hurts.  // Consumer Reports on Health;Jul99, Vol. 11 Issue 7, p10 

    Provides information on peripheral vascular disease generally caused by plaque buildup in an artery. Pain triggered by walking as a symptom that the working muscles are not getting enough oxygen; Diagnosis and treatment by a medical practitioner.

  • Carotid Endarterectomy for Asymptomatic Stenosis - Firming Up on the Uncertainty. Warlow, Charles // Practical Neurology;Feb2005, Vol. 5 Issue 1, p2 

    The article focuses on a widespread disease called asymptomatic carotid stenosis. It is almost always due to atheroma. Atheroma is generally a widespread disease; if it affects one artery it probably affects others. So although carotid stenosis may be asymptomatic in the sense that there have...

  • Gene expression differences during the heterogeneous progression of peripheral atherosclerosis in familial hypercholesterolemic swine. Bahls, Martin; Bidwell, Christopher A.; Juan Hu; Tellez, Armando; Kaluza, Greg L.; Granada, Juan F.; Krueger, Christian G.; Reed, Jess D.; Laughlin, M Harold; Van Alstine, William G.; Newcomer, Sean C. // BMC Genomics;2013, Vol. 14 Issue 1, p1 

    Background: The heterogeneous progression of atherosclerotic disease in the peripheral arteries is currently not well understood. In humans, artery specific disease progression is partly attributed to the local hemodynamic environments. However, despite similar hemodynamic environments, porcine...

  • Treatment of Cardiovascular Risk Factors in PAD. Wellbery, Caroline // American Family Physician;6/1/2003, Vol. 67 Issue 11, p2382 

    Discusses the study 'Atherosclerotic Risk Factor Reduction in Peripheral Arterial Disease. Results of a National Physician Survey,' by M.M. McDermott et al., from the December 2002 issue of the 'Journal of General Internal Medicine.'

  • Peripheral vascular disease. Lawrence, Matthew; Stephenson, James; Al-taan, Omer; McCarthy, Mark J. // InnovAiT;Jul2011, Vol. 4 Issue 7, p399 

    Peripheral vascular disease (PVD) is a chronic condition caused by atheroma formation, resulting in reduced blood flow to the tissues. It presents in a wide spectrum of ways ranging from pain experienced on exercise (intermittent claudication), through pain at rest preventing sleep at night, to...

  • STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. Sikorski, Krzysztof; Chmielewski, Stefan; Olejnik, Adam; Wesoly, Joanna Z.; Heemann, Uwe; Baumann, Marcus; Bluyssen, Hans // JAK-STAT;Oct-Dec2012, Vol. 1 Issue 4, p1 

    Atherosclerosis is characterized by early endothelial dysfunction and altered vascular smooth muscle cells (VSMCs) contractility. The forming atheroma is a site of excessive production of cytokines and inflammatory ligands by various cell types that mediate inflammation and immune responses. Key...

  • Docs here to 'shave' plaque from arteries. Parish, Linn // Journal of Business (10756124);10/28/2004, Vol. 19 Issue 22, pB1 

    Reports the plan of Deaconess Medical Center of Spokane, Washington, to use a procedure, called atherectomy, to treat peripehral vascular disease. Description of the plaque-removal device; Surgical process; Manufacturer of the device.

  • Trimetazidine hydrochloride as a new treatment for patients with peripheral vascular disease - an exploratory trial. CHU, Y.-S.; LI, D.-X.; ZHANG, M.; JIANG, T.-M. // European Review for Medical & Pharmacological Sciences;Jan2016, Vol. 20 Issue 1, p188 

    OBJECTIVE: To evaluate the therapeutic effect of trimetazidine hydrochloride in peripheral vascular disease patients who had Rutherford classification grade 2-3. PATIENTS AND METHODS: 72 patients with Rutherford classification grade 2-3 in peripheral vascular were recruited successfully, they...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics